In terms of hypertension control, one meta-analysis revealed that sex-specific outcome data were only reported in 43% of clinical trials reviewed, with ACE inhibitors and ARBs showing a small increase in cardiovascular benefit in men versus women [154]. Here, ACE is linked to Hypertension.